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Key point summary:  
• Children with cystic fibrosis undergoing lung transplant harbour multiple subpopulations of M. 
abscessus. 
• Subpopulations can have different antimicrobial resistance genotypes. 
• Sputum isolates do not reflect the genetic diversity within a patient.   
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Abstract  
Background: Children with cystic fibrosis (CF) can develop life-threatening infections of 
Mycobacterium abscessus. These present a significant clinical challenge, particularly when the strains 
involved are resistant to antibiotics. Recent evidence of within-patient subclones of M. abscessus in 
adults with CF suggests the possibility that within-patient diversity may be relevant for the treatment of 
pediatric CF patients.  
Methods: We performed whole genome sequencing (WGS) on 32 isolates of M. abscessus from 
multiple body sites for two patients with CF undergoing treatment at Great Ormond Street Hospital, 
UK, in 2015. 
Results: We found evidence of extensive diversity within patients over time. Clustering analysis of 
single nucleotide variants (SNVs) revealed that each patient harboured multiple subpopulations, 
which were differentially abundant between sputum, lung samples, chest wounds, and pleural fluid. 
Sputum isolates did not reflect overall within-patient diversity, including failing to detect subclones with 
mutations previously associated with macrolide resistance (rrl 2058/2059). Some variants were 
present at intermediate frequencies before lung transplant. The time of transplant coincided with 
extensive variation, suggesting that this event is particularly disruptive for the microbial community, 
but transplant did not clear the M. abscessus infection and both patients died as a result of this 
infection. 
Conclusions: Isolates of M. abscessus from sputum do not always reflect the entire diversity present 
within the patient, which can include subclones with differing AMR profiles. Awareness of this 
phenotypic variability, with sampling of multiple body sites in conjunction with WGS, may be 
necessary to ensure the best treatment for this vulnerable patient group. 
  
.CC-BY 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/436261doi: bioRxiv preprint first posted online Oct. 5, 2018; 
 M. abscessus subclones in CF patients 
3 
 
 
 
 
Introduction 
Mycobacterium abscessus is a nontuberculous mycobacteria (NTM) which has recently emerged as a 
major pathogen in cystic fibrosis (CF) patients1. Infection with M. abscessus is associated with poor 
clinical outcomes, particularly in conjunction with lung transplantation2. Treatment is challenging due 
to the intrinsic resistance of M. abscessus to many classes of antibiotics3, along with certain 
genotypes drastically altering the efficacy of antibiotic courses4. The antimicrobial resistance (AMR) 
profile of isolates is highly relevant for treatment, but current diagnostic work mainly uses isolates 
from sputum, which may not reflect the full range of genetic diversity within the patient and therefore 
fail to recover the true AMR profile. 
Minority variants from WGS have been used to infer the presence of multiple subpopulations 
(subclones) in longitudinal sputum isolates of M. abscessus5. However, it remains an open question 
whether patients harbour further genetic diversity within the lung that is not sampled by sputum. The 
lung is known to be capable of harbouring considerable pathogen diversity in chronic infections. For 
example, M. tuberculosis has been shown to exist as multiple subpopulations with different AMR 
profiles6. Furthermore, the relevance of this genetic diversity for treatment is not yet known. 
For this reason, we investigated longitudinal isolates from two patients infected with M. abscessus 
subsp. abscessus undergoing lung transplant at Great Ormond Street Hospital (Figure 1), and 
identified variable genomic positions within samples (single nucleotide variants, SNVs). By including 
isolates from sputum samples but also biologically important compartments such as pleural fluid, lung 
tissue, and swabs from chest wounds, we aimed to establish the extent and significance of within-
patient variation in M. abscessus for this vulnerable group. 
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Figure 1. Overview of the sampling scheme and antibiotic treatment. Treatment regime including 
intravenous antibiotics (boxed coloured lines) and oral antibiotics (faint coloured lines) for both 
patients during the six-month period prior to lung transplant (red vertical line). The sampling scheme 
is represented at the bottom of each panel (coloured points on grey background).  
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Methods 
Patient cohort and sample collection 
Great Ormond Street Hospital (GOSH) is a large regional centre for paediatric CF patients and the 
largest paediatric lung transplant centre in the UK. The two patients in this study (Patient 1 and 
Patient 2) were from other CF centres and were seen at GOSH for a transplant assessment, during 
the lung transplant procedure and post-transplant (Table 1). Both patients in this study underwent 
regular respiratory microbiological diagnostic investigations, including specific stain and culture for 
mycobacteria on sputum pre- and post-transplant and explanted lung tissue, bronchoalveolar lavage, 
pleural fluid and clamshell incision wound swabs post-transplant. All further microbiological 
investigations were carried out on ‘sweeps’ from pure culture plates. All M. abscessus isolates 
cultured in our laboratory are identified to sub-species level by PCR and sequencing of hsp65 and 
rpoB genes and inducible macrolide resistance predicted by PCR and sequencing of the erm(41) 
gene as previously described7. VNTR profiles were obtained for selected isolates as previously 
described8. Phenotypic sensitivity data was obtained from the mycobacterial reference laboratory 
(Table 3).  
Demographic and clinical data were extracted from the Patient Administration System (PIMS) and 
microbiological data from the Laboratory Information Management system (OMNI-client ISS) using 
SQL (structured query language) databases and Excel spreadsheets. Additional sources of 
information included CF and transplantation databases. Details of antimicrobial therapy administered 
prior to transplantation was provided by the referring CF centres. All investigations were performed in 
accordance with the Hospitals Research governance policies and procedures.  
Whole genome sequencing  
16 isolates from Patient 1 and 16 isolates from Patient 2 underwent DNA extraction as previously 
described8 with the addition of a bead beating step. Total DNA concentration was determined using 
the Qubit high-sensitivity (HS) assay kit (Thermofisher) and a sequencing library was prepared from 
50 ng of DNA using the Nextera Library Preparation kit (Illumina). Post-PCR clean-up was carried out 
using Ampure XP beads (Beckman). Library size was validated using the Agilent 2200 TapeStation 
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with Agilent D1000 ScreenTape System and 150bp paired-end reads were sequenced on a NextSeq 
550 system (Illumina). Raw sequencing reads have been deposited on ENA (Study Accession 
PRJEB28875) as well as two assemblies used as ‘de novo references’ (see below).  
Sequence data analysis 
Initial variable nucleotide tandem repeat (VNTR) typing carried out as described previously8,9 
suggested the possibility of mixed infections, based on results intermediate between VNTR I and the 
closely related VNTR I* profile (differing at one locus). A preliminary mapping of all isolates to the 
standard M. abscessus strain ATCC 19977 chromosome (NCBI Accession: CU458896.1) showed 
that the mean coverage at 10X was ~91%, contrasted with >99% for a representative set of VNTR II 
isolates from another patient sequenced according to the same protocol (not shown). In order to 
ensure we captured as much of the genetic diversity as possible, we therefore adopted a hybrid de 
novo and mapping approach. We selected the first isolate (temporally) for each patient and performed 
de novo assembly with Spades v3.10.0 with the --careful switch and otherwise default parameters10. 
After removing contigs with <10,000 bases to reduce the possibility of including small mobile genetic 
elements, this first de novo assembly was used as a new reference to map raw reads from other 
isolates using bwa mem v0.7.12 with default parameters11. This produced ‘de novo references’ for 
Patient 1 and Patient 2 containing 5.17Mb and 5.28Mb respectively (Table 1). Contigs were reordered 
against the M. abscessus ATCC 19977 chromosome using Mauve v2.4.0 (2015-02-25)12. 
Variant identification and clustering analysis 
In brief, the mapping file was sorted and indexed using picard v1.130, then GATK v3.30 was used to 
create a combined variant call format (VCF) file for each patient. Each position required a mapping 
depth > 30 in all samples from a patient to be included in downstream analysis. We manually 
inspected the ‘self-mapping’ of the reads from the first temporal sample to its own de novo assembly 
using IGV v2.4.1013 to identify small regions where mapping was problematic. We removed SNVs 
within isolated regions where the self-mapping had unexpected peaks in coverage (Patient 1: contigs 
12 (12,575-13,519bp) and 19 (96,916-97,032bp); Patient 2: contig 17 (12,718-12,770bp) as well as 
SNVs where the reference allele fraction from the self-mapping reads was < 5%. 
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As noted by Bryant et al.5, patterns of linkage of variants in for M. abscessus can be suggestive of the 
existence of subpopulations. We aimed to establish a conservative lower bound for the number of 
clonal subpopulations within a patient, inferring their existence from the linkage patterns of variant 
frequencies across all samples. We note that patterns of linkage disequilibrium can also occur due to 
recombination. We therefore attempted to remove local recombination in our analysis. Using the 
SNVs obtained via the mapping and filtering methods described above, we hierarchically clustered 
SNVs using Ward’s minimum variance criterion14 applied to Euclidean distances between allele 
frequencies with a dissimilarity threshold of 1 to define clusters. We removed clusters containing <4 
SNVs. We also removed putative local recombination regions by removing clusters where the SNVs 
were distributed within a total range < 100,000bp (corresponding to a threshold of ~2% of the total 
length of the M. abscessus genome).  
In general, the inference of haplotype frequencies using variant frequencies from short sequencing 
reads for a microbial population undergoing recombination is a complex problem15. However, as we 
are not attempting to comment on abundances of subpopulations but only their presence, we did not 
need to infer haplotype frequencies. Observing n distinct clusters of variants within a patient over time 
(i.e. allele frequencies that co-vary in step with each other) means that there must be at least n 
bacterial haplotypes within the population producing these patterns. This fact holds even when 
recombination is present. Therefore, observing distinct clusters of linked variants tells us that distinct 
subpopulations of M. abscessus exist within individual samples.  
Results 
Individuals harbour extensive variation 
We observed multiple positions in the M. abscessus genome which varied between different isolates 
within a patient over time (total variable positions used for clustering across all isolates, patient 1: 54 
positions, patient 2: 64 positions), although isolates remained highly similar on average and were 
clearly the same infecting strain (mean inter-isolate SNV distances patient 1: 2.07 +/- 0.92 SNVs, 
patient 2: 1.96 +/- 1.81 SNVs). Subsets of these SNVs showed patterns of linkage across the M. 
abscessus genome (Figure 2a). Similar clustered patterns of linked SNVs could also arise due to 
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recombination, but the final groups of clustered SNVs were spread across the genome suggesting 
that multiple subclones were present. Even if recombination were present, leading to mixtures of 
clusters (i.e. different haplotypes), then the observed abundance patterns still required multiple 
subclones. A neighbour-joining tree produced from distances between isolates based on these allele 
frequencies suggested the presence of multiple subclones (Figure 2b).  
Figure 2. Linkage patterns of SNVs across samples suggest the presence of closely-related 
subpopulations within patients. (a, b) SNVs were grouped into clusters (colours) using an 
unsupervised clustering technique, showing clear patterns of abundance across samples (see 
Methods). Genome position was inferred by ordering de novo contigs against the M. abscessus 
ATCC 19977 reference genome. (c, d) Midpoint-rooted neighbour-joining tree based on Euclidean 
distances between samples using these clustered SNVs show this variation within patients over time 
(numbers) and body site (colours). 
Within-patient variation includes antimicrobial resistance mutations 
Macrolide resistance in M. abscessus is driven by mutations at well-established positions in the rrl 
gene. Both patients received macrolides almost continuously throughout the six months prior to 
transplant (patient 1: oral azithromycin, patient 2: oral clarithromycin). While initial isolates taken 
earlier in treatment were susceptible, we observed that resistance alleles at these positions (C/G) 
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increased in abundance over time (Figure 3). Notably, all sputum isolates from patient 1 showed a 
susceptible allele at position 2059 whereas isolates from pleural fluid and clamshell incision wound 
swabs carried a resistance allele (A2059C, Figure 3a). There was also substantial variation within 
sets of isolates taken on the same day. For example, three isolates from different samples of lymph 
node tissue taken on the day of transplant for patient 2 showed completely different macrolide 
resistance profiles, most striking at position 2058 (Figure 3b). These positions were not among the 
SNVs clustered into subpopulation structure clusters in patient 2, but rrl 2059 was part of cluster 1.D 
in patient 1, demonstrating that these resistance alleles can arise spontaneously but also persist 
linked to genetic background. 
 Figure 3. Variants in the rrl gene (23S rRNA) arise during treatment and are present in isolates 
from concurrent samples. Relative allele fractions at these positions show that although the initial 
sputum isolate was susceptible for both patients, resistance appeared to develop during treatment. 
Samples are ordered by time, with boxes indicating samples on the same day. Samples taken on the 
day of transplant are shown in bold text. N.B. Here following the usual convention for the rrl gene we 
use E. coli numbering. Positions 2058 and 2059 in E. coli correspond to 2269 and 2270 in M. 
abscessus. (S = sputum, BAL = bronchalveolar lavage, CW = chest wound, DSW = drain site swab, 
LT = lung tissue, LN = lymph node, PF = pleural fluid). 
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Figure 4. Variants in the rrs (16S rRNA) gene over the course of treatment. Patient 1: position 
1174. Patient 2: position 1374, previously associated with amikacin resistance (see text). Numbering 
relative to ATCC 19977 reference. (S = sputum, BAL = bronchalveolar lavage, CW = chest wound, 
DSW = drain site swab, LT = lung tissue, LN = lymph node, PF = pleural fluid). 
 
We also observed variable positions in the rrs gene in both patients (Figure 4). The rrs gene codes for 
16S rRNA and is often a site of the emergence of aminoglycoside resistance (e.g. to amikacin), 
particularly the last few 100bp of the gene where the secondary structure of the rRNA can be affected 
by multiple mutations16. The de novo reference assembly for the gene in both patients was identical to 
the previously characterised sequence from amikacin-resistant M. abscessus16,17, which was 
consistent with the measured AMR phenotype of the first sputum sample in Patient 2 but not Patient 1 
(Table 3). Subsequently, the patient_1_S2 isolate from lung tissue on the day of transplant had a 
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different allele at position 1174 (C→T; Figure 4), and was partially resistant when phenotyped (Table 
3), suggesting this mutation may have been involved in this resistance. In Patient 2, we observed both 
A and G at position 1374, corresponding to the A1400G mutation which confers high-level amikacin 
resistance in M. tuberculosis18. The G allele was dominant by the end of treatment, suggesting that it 
may have conferred higher resistance and/or been an important compensatory mutation. 
Other sites also showed high levels of variation in both patients. After sorting SNVs by the standard 
deviation of the reference allele fraction across isolates (Supplementary Dataset 1), the most highly 
variable position in patient 1 was in the putative ferric uptake regulator FurB (MAB_1678c). This 
variant was present at high abundance in samples 49 days after transplant, with the reference allele 
fraction only present at <2% in one pleural fluid sample (Supplementary Dataset 1). Ferric uptake 
regulation has been associated with virulence of pathogenic mycobacteria; in mycobacterial infections 
the host response deprives the bacteria of iron to prevent replication19. Iron is important for growth 
and virulence in M. abscessus20 with gallium used as a treatment because of its ability to inhibit iron-
dependent enzymes21. The most variable position in patient 2 was within a putative linoleoyl-CoA 
desaturase (MAB_2148), and the second most highly variable position in patient 2 was within the cell 
division control protein 48 CDC48 (MAB_0347). Population heterogeneity via asymmetric cell division 
has been suggested as a factor facilitating the survival of M. tuberculosis across host physiological 
niches22, and the control of cell division is probably similarly important in the survival of M. abscessus 
across body sites. Both patients had a variable position within erm(41) (MAB_2297) although at 
different positions, which confers inducible resistance to macrolides23. 
Sputum samples do not reflect overall within-patient diversity 
The first sample from both patients was from sputum. Frequencies of the reference alleles were 
significantly associated with body site in Patient 2 (Kruskal-Wallis rank-sum test, p<0.001) but not 
Patient 1 (Kruskal-Wallis rank-sum test, p=0.13). Reference allele frequencies were significantly 
higher in subsequent sputum isolates compared to non-sputum isolates for the majority of SNVs in 
both patients (Patient 1: 51/54 SNVs with p<0.05 after Benjamini-Hochberg correction, Patient 2: 
61/64 SNVs with p<0.05 after Benjamini-Hochberg correction), suggesting that sputum isolates 
tended to be more similar to the initial sputum isolate used as a reference, even for Patient 1 where 
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3/3 subsequent sputum isolates were post-transplant (immunosuppressed). This also suggests that 
non-sputum isolates harboured additional diversity that was not well-sampled using sputum.  
Discussion 
In this retrospective study we sought to establish the extent of within-patient variability of M. 
abscessus in two patients who developed severe complications following lung transplant as part of 
treatment for CF. We used WGS to characterise this variability in isolates from longitudinal clinical 
samples, and were able to reveal patterns of linkage of SNVs consistent with the presence of multiple 
subpopulations within patients.  
While isolates from the same patient were similar — for example, all inter-isolate distances for the 
same patient were within the threshold of 25 SNVs previously suggested for inferring potential 
transmission events24 — this does not mean that the variation is not clinically significant. We have 
demonstrated that within-patient variation can contain biologically and clinically important variation. 
Notably, we observed that variation at the rrl 2058/2059 positions, associated with macrolide 
resistance, developed over the course of treatment. We observed extensive variation in lung tissue 
isolates taken from Patient 41 prior to and on the day of transplant (i.e. before the patient was 
immunosuppressed). Isolates from Patient 1 samples taken prior to and on the day of transplant 
displayed no variation at these positions, so presumably the phenotypic macrolide resistance reported 
in these samples at this time was due entirely to inducible resistance conferred by erm(41). 
Nonetheless, variation at rrl 2058/2059 positions was seen in later samples from this patient, 
suggesting that macrolide use still drives development of high-level macrolide resistance even in the 
presence of a functional erm(41) gene. We also observed variation in the rrs gene, another source of 
resistance to antibiotics targeting ribosomal function (e.g. amikacin), at both previously recorded and 
novel positions, including an allele that rose in dominance over the course of treatment in Patient 2 
(Figure 4). 
Based on this data we would question how useful phenotypic testing of isolates recovered from a 
limited number of sputum isolates is for guiding antimicrobial therapy, as this strategy is unlikely to 
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capture the diversity present in a single sample. Similarly, even though WGS is clearly a valuable tool, 
if restricted to the analysis of sputum isolates it may also fail to capture an accurate AMR profile of an 
infection. Previous studies on M. tuberculosis have shown that mycobacterial culture reduces the 
diversity recovered from sputum samples whether the culture was enriched in solid or liquid 
media25,26. It is therefore possible that the diversity found across different sample sites in this study 
may have been present in the sputum sample, but was possibly lost in the culture step. For M. 
tuberculosis, direct sequencing from sputum samples using capture-based enrichment methods has 
been shown to recover sample diversity not present in liquid culture27. Extending this to this case, it is 
possible that WGS at high depth applied directly to sputum samples could identify the variants 
detected between sample sites.  
Other highly variable positions in genes involved in e.g. the regulation of ferric uptake (MAB_1678c) 
and the control of cell division (MAB_0347), are both of direct relevance for the survival of M. 
abscessus across different physiological niches. In a chronic infection, mycobacteria must cope with 
considerable host stresses, including Fe starvation, which has been highlighted as enabling the 
persistence of M. tuberculosis in granulomas28. There is also, of course, phenotypic diversity due to 
expression. For example, colony morphotype has previously been suggested as providing a 
distinction between a ‘non-invasive, biofilm-forming, persistent phenotype’ (smooth) and an ‘invasive 
phenotype that is unable to form biofilms’ (rough), although recent work suggests both morphotypes 
are capable of aggregation and intracellular survival29. Further diversity may come from the 
subpopulations harboured at different locations within the patient’s lung, which may therefore be an 
important source of diversity for clinically significant phenotypes. 
There is also the possibility that this within-patient variability could lead to different transmission 
inferences, if different lineages of M. abscessus can be present in the lung together. However, the 
variation found within each of the two patients in this study, who were both infected with a clonal 
VNTR I strain, did not exceed the variation found between them. 
Our findings suggest that the wider diversity present within patients chronically infected with M. 
abscessus is not well-sampled with sputum, and that body site plays a role in subpopulation structure. 
More widespread sampling of multiple body sites would provide a more accurate picture of the AMR 
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profile of M. abscessus infecting a patient, and may be necessary to guide targeted antimicrobial 
therapy prior to transplant. However, in practical terms this would mean taking biopsies of lung and 
other tissue, which carries a significant clinical risk and would probably be unfeasible in the patient 
awaiting transplant. An alternative solution to improve patient management prior to transplant might 
rely on deep-sequencing of multiple sputum samples. Such a strategy might capture a sufficient 
fraction of the diversity seen with multiple body site sampling to provide accurate information about 
the presence of minor variants present in M. abscessus infections of CF patients, in particular those 
conferring AMR. 
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Tables 
 
 
Patient 1 Patient 2 
Total bases 5,172,759 5,275,491 
Mean depth of coverage  25.3X  74.1X 
Number of contigs  28 46 
 
Table 1. Summary statistics for the de novo reference genomes of the two patients in this 
study. References were assembled for the first temporal sample from each patient (patient_1_S1 and 
patient_2_S1; see Methods). 
Table 2: patient clinical data. Dates are relative to the day of transplant.  
 
 
Patient M. abscessus  
sub-species Sex CF genotype 
Date of last 
smear-positive 
sample 
Date of last 
M. 
abscessus 
isolate 
Patient 1 ABS Female F508del/F508del -166 days +56 days 
 Patient 2 ABS Male F508del/W1282X -81 days +59 days 
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Sample Body site Date isolated 
Colony 
morphotype 
VNTR 
profile Phenotypic susceptibility 
patient_1_S1 Sputum -166 
days 
Rough I Amikacin-S; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Augmentin-R 
patient_1_S2 Lung tissue 0 days Rough I Amikacin-PR; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trem-R; 
Cefotaxime-R 
patient_1_S3 Sputum 10 days Smooth I n/a 
patient_1_S4 Sputum 15 days Rough I n/a 
patient_1_S5 Pleural Fluid 21 days Smooth I n/a 
patient_1_S6 Pleural Fluid 38 days Rough I* n/a 
patient_1_S7 Pleural Fluid 38 days Rough I* n/a 
patient_1_S8 Pleural Fluid 40 days Smooth I* n/a 
patient_1_S9 BAL 42 days Smooth I* n/a 
patient_1_S10 Pleural Fluid 49 days Smooth I* n/a 
patient_1_S11 Pleural Fluid 49 days Smooth I* n/a 
patient_1_S12 Pleural Fluid 49 days Smooth I* n/a 
patient_1_S13 Chest wound 
swab 
49 days Smooth I / I* n/a 
patient_1_S14 Chest wound 
swab 
49 days Smooth I n/a 
patient_1_S15 Sputum 51 days Smooth I / I * n/a 
patient_1_S16 Chest wound 
swab 
56 days Rough I n/a 
      
patient_2_S1 Sputum -121 
days 
Rough n/a Amikacin-R; Cipro-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trem-R; 
Cefotaxime-R 
patient_2_S2 Sputum -81 days Smooth I n/a 
patient_2_S3 Lymph node 
tissue 
0 days Rough I n/a 
patient_2_S4 Lymph node 
tissue 
0 days Smooth n/a n/a 
patient_2_S5 Lymph node 
tissue 
0 days Rough I n/a 
patient_2_S6 Lung tissue 0 days n/a I n/a 
patient_2_S7 Sputum 14 days Smooth n/a n/a 
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Table 3: Routine microbiology data about isolates in this study. Dates are relative to the date of 
transplant for each patient. An asterisk (*) indicates that the VNTR profile differed at one locus. n/a 
indicates data not available. Phenotypic susceptibility was available for a minority of isolates 
(S=susceptible, R=resistant, PR=partially resistant).  
Supplementary data 
Supplementary Dataset 1. SNVs used for clustering in both patients. A list of the variant 
positions used for clustering to identify subpopulations, sorted in decreasing order of standard 
deviation across samples. In addition to the position of the variant in the de novo assembly reference, 
its position (if present) in the ATCC 19977 is given, along with the relevant UniProt ID. Samples are 
sorted in time order.  
 
patient_2_S8 BAL 27 days Smooth I n/a 
patient_2_S9 Pleural Fluid 33 days Smooth I n/a 
patient_2_S10 BAL 41 days Smooth I / I* n/a 
patient_2_S11 Pleural Fluid 42 days Smooth I n/a 
patient_2_S12 Pleural Fluid 42 days Smooth I Amikacin-R; Ciprofloxacin-R; 
Clarithromycin-R; Doxycycline-R; 
Linezolid-R; Co-trimoxazole-R; 
Cefoxitin-R; Tobramycin-R; 
Moxyfloxacin-R 
patient_2_S13 Drain site 
swab 
49 days Smooth n/a n/a 
patient_2_S14 Pleural Fluid 50 days Smooth n/a n/a 
patient_2_S15 Pleural Fluid 58 days Smooth I n/a 
patient_2_S16 Pleural Fluid 59 days Smooth n/a n/a 
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